ArticleInternational journal of antimicrobial agents2023

Meropenem-vaborbactam restoration of first-line drug efficacy and comparison of meropenem-vaborbactam-moxifloxacin versus BPaL MDR-TB regimen.

Sanjay Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.